Abstract
Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 457-467 |
| Number of pages | 11 |
| Journal | Personalized Medicine |
| Volume | 8 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2011 |
Fingerprint
Keywords
- BRCA
- gene-expression profiling
- genetics
- lawsuit
- liability
- litigation
- pharmacogenomics
- physician liability
- whole-genome sequencing
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology
- Medicine(all)
Cite this
Physician liability : The next big thing for personalized medicine? / Marchant, Gary; Campos-Outcalt, Doug E.; Lindor, Rachel A.
In: Personalized Medicine, Vol. 8, No. 4, 07.2011, p. 457-467.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Physician liability
T2 - The next big thing for personalized medicine?
AU - Marchant, Gary
AU - Campos-Outcalt, Doug E.
AU - Lindor, Rachel A.
PY - 2011/7
Y1 - 2011/7
N2 - Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.
AB - Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.
KW - BRCA
KW - gene-expression profiling
KW - genetics
KW - lawsuit
KW - liability
KW - litigation
KW - pharmacogenomics
KW - physician liability
KW - whole-genome sequencing
UR - http://www.scopus.com/inward/record.url?scp=79960954006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960954006&partnerID=8YFLogxK
U2 - 10.2217/pme.11.33
DO - 10.2217/pme.11.33
M3 - Article
VL - 8
SP - 457
EP - 467
JO - Personalized Medicine
JF - Personalized Medicine
SN - 1741-0541
IS - 4
ER -